This research tests a new personalised care model for Parkinson’s called Prime Care, offering rapid access to support and tailored interventions based on each patient’s risk of hospital admission. A two-year clinical trial of 214 participants will determine whether this approach improves wellbeing and reduces costly, harmful hospital stays.

The researcher rebuilds how cells sort materials to understand Alzheimer’s and Parkinson’s diseases. Using proteins and lipids like Lego pieces, they study how a key protein, retromer, malfunctions and disrupts cell transport. With cryogenic electron tomography, they aim to model this process and guide new treatments that restore healthy cellular function.